Skip to content

Craniotomy and Duraplasty versus Craniotomy, lobectomy and duraplasty Operations in sever head trauma patients

Evaluation the efficacy of Craniotomy and Duraplasty versus Craniotomy, lobectomy and duraplasty Operations in acute traumatic subdural hematoma

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013051313307N1
Enrollment
96
Registered
2013-05-26
Start date
2012-01-18
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic subdural hematoma. Traumatic subdural haemorrhage

Interventions

Group II: Craniotomy, Duraplasty and Lobectomy operations
Group I: Craniotomy and Duraplasty operations
Intervention 1: Group II: Craniotomy, Duraplasty and Lobectomy operations. Intervention 2: Group I: Craniotomy and Duraplasty operations.
Treatment - Surgery

Sponsors

Research Council of Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients higher than 18 years old, with traumatic subdural hematoma; patients with intracranial hypertension evidence, and patients with Glasgow outcome score (GCS) lower or equal to 8 before surgery. Exclusion criteria: patients with peripheral or central neuropathy before surgery; patients with metabolic syndrome.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Glasgow coma scale. Timepoint: pre and post operative evaluation. Method of measurement: Assessment of awareness by Glasgow coma scale questionnaire.

Secondary

MeasureTime frame
Mortality rate and Glasgow Outcome Scale. Timepoint: 3 months after surgery. Method of measurement: Assay the mortality and disability after operation by Glasgow Outcome Scale questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Fariba Housmandi

Mashhad University of Medical Sciences

HoushmandiF881@mums.ac.ir+98 51 1846 5779

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026